Ensuring Patient Access to Critical Breakthrough Products Act of 2018
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in house (Jun 5, 2018)
Ensuring Patient Access to Critical Breakthrough Products Act of 2018
This bill (1) allows designated medical breakthrough devices to be temporarily covered under Medicare during a specified transitional period, (2) establishes a process to allow for continued coverage after the transitional period has expired, and (3) modifies other Medicare payment systems relating to new medical technology.
What just happenedJun 8, 2018
Referred to the Subcommittee on Health.
Who’s behind it
- Introduced in HouseJun 5, 2018
- Jun 8, 2018Committee
Referred to the Subcommittee on Health.
Health Subcommittee - Jun 5, 2018IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Energy and Commerce Committee - Jun 5, 2018IntroReferralH11100
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Ways and Means Committee - Jun 5, 2018IntroReferralIntro-H
Introduced in House
- Jun 5, 2018IntroReferral1000
Introduced in House